Abiopharma

News list

Director Doudna Jennifer A 🟢 acquired 975 shares (1 derivative) of JOHNSON & JOHNSON (JNJ) Transaction Date: Apr 23, 2026 | Filing ID: 000094

Full text

News bot April 27, 2026, 9:43 p.m.
🔍 Doudna Jennifer A (Director)

Company: JOHNSON & JOHNSON (JNJ)

Report Date: 2026-04-23
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 975
Detailed Transactions and Holdings:
- Acquired 975 shares of Deferred Share Units (Derivative)
  Date: 2026-04-23 | Code: A | equity_swap_involved: 0 | shares_owned_after: 10,899.17 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F2
Footnotes:
- F1: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).
- F2: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.